Ringworm Market Size to Grow at a CAGR of 3.49% during 2024-2034, Impelled by Advancements in Early Detection

November 28, 2024 | Healthcare

VIEW FULL TABLE OF CONTENTS

Ringworm Market Outlook 2024-2034:

The ringworm market size is expected to exhibit a CAGR of 3.49% during 2024-2034. The market is driven by the emerging popularity of intravenous griseofulvin therapy to treat severe disease conditions owing to its various benefits, like a quicker onset of action, enhanced absorption, and improved compliance. Additionally, the development of targeted therapies and innovative treatments is further propelling the market growth.

Advances in Early Detection and Diagnostic Technologies: Driving the Ringworm Market

Advances in early detection and diagnostic technologies are significantly driving the ringworm market, facilitating timely diagnosis and effective treatment of this widespread fungal infection. Traditional diagnostic methods, such as microscopic examination of skin scrapings and fungal cultures, are being enhanced by modern molecular technologies. Polymerase chain reaction (PCR)-based assays have emerged as highly sensitive and specific tools for detecting dermatophyte DNA, significantly reducing diagnostic time compared to cultures, which can take weeks. These advancements are enabling precise identification of fungal species, ensuring targeted and effective treatment while minimizing the risk of resistance. Non-invasive imaging technologies, such as dermoscopy, are becoming essential tools for clinicians. Dermoscopy allows for magnified visualization of skin lesions, helping to differentiate ringworm from conditions like eczema or psoriasis. This immediate, in-office diagnostic capability reduces delays in initiating treatment, improving patient outcomes. Furthermore, point-of-care diagnostic kits are gaining popularity for their convenience and rapid results. These tools are especially valuable in resource-limited settings, expanding access to timely diagnosis. Besides this, the integration of modern technologies with telemedicine platforms further enhances diagnostic reach. Patients in remote areas can upload images of suspected lesions for expert evaluation, ensuring early intervention. These advancements in early detection are driving demand for antifungal treatments and supporting market growth, ultimately improving the quality of care and outcomes for patients affected by ringworm.

Development of Novel Therapies and Pharmacological Treatments: Contributing to Market Expansion

The development of novel therapies and pharmacological treatments is significantly contributing to the expansion of the ringworm market. One key advancement is the development of novel antifungal formulations with improved efficacy and patient adherence. Long-acting topical agents, such as those incorporating liposomal or nanoparticle delivery systems, ensure sustained drug release and deeper penetration into affected tissues, leading to better treatment outcomes. Similarly, new oral antifungal agents with broader spectrums of activity and fewer adverse effects are enhancing systemic treatment options, particularly for severe or resistant infections. Biologic therapies are emerging as an innovative approach, targeting specific fungal components or immune pathways to enhance treatment efficacy. These targeted therapies may reduce the duration of treatment and minimize side effects, offering a significant improvement over traditional antifungals. Research into combination therapies is also expanding, with clinical trials exploring the synergistic effects of antifungal agents combined with anti-inflammatory drugs. These combinations aim to address both the fungal infection and the associated symptoms, such as itching and inflammation, providing comprehensive relief. Point-of-care diagnostic tools and advancements in telemedicine further support the ringworm market by enabling earlier and more accurate diagnosis, which directly drives demand for these novel treatments. Increased awareness among healthcare providers and patients about these advanced therapeutic options is further fueling market growth. Moreover, these innovations not only improve patient outcomes by addressing gaps in current treatments but also create significant opportunities for market expansion, ensuring that ringworm management continues to evolve in response to patient needs.

Marketed Therapies in Ringworm Market

Naftin gel (Naftifine topical): Sebela Pharmaceuticals

Naftin gel is a topical (for the skin) antifungal medication used to treat skin infections such as ringworm infections. It is a synthetic broad-spectrum antifungal agent and allylamine derivative. The drug mainly appears to interfere with sterol production by blocking the enzyme squalene 2,3-epoxidase. This inhibition of enzyme activity results in lower levels of sterols, particularly ergosterol, and a buildup of squalene in the cells.

Lamisil (Terbinafine): Novartis

Lamisil (Terbinafine) is an allylamine antifungal used to treat ringworm infections of toenails and fingernails as well as other fungal skin infections. Terbinafine inhibits the enzyme squalene monooxygenase (also known as squalene epoxidase), which prevents the conversion of squalene to 2,3-oxydosqualene, a stage in the generation of ergosterol. This inhibition results in less ergosterol, which would normally be absorbed into the cell wall, and a buildup of squalene.

Mentax (Butenafine): Kaken Pharmaceutical

Mentax (Butenafine) is a topical antifungal used to treat tinea versicolor, tinea pedis, tinea cruris, and tinea corporis. Butenafine disrupts sterol biosynthesis (particularly ergosterol) by inhibiting squalene monooxygenase, an enzyme that converts squalene to 2,3-oxydo squalene. Ergosterol is a key component of the fungal cell membrane, hence inhibiting its synthesis causes increased cellular permeability and leaking of cellular contents. Blockage of squalene monooxygenase causes squalene buildup. When a high concentration of squalene is attained, it is expected to kill fungal cells directly.

Luzu (Luliconazole)

Luzu (luliconazole) cream, 1%, is used to treat interdigital tinea pedis, tinea cruris, and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum in patients aged 18 and above. Luliconazole is known to inhibit the enzyme lanosterol demethylase. Lanosterol demethylase is required for the formation of ergosterol, a key component of fungal cell membranes.

Emerging Therapies in Ringworm Market

DBI-001: DermBiont

DBI-001, developed by DermBiont, is a topical live biotherapeutic agent designed to treat fungal skin infections like ringworm (tinea corporis). Its mode of action is the administration of beneficial bacteria to the skin, which aids in the restoration of a healthy microbial balance. This repair limits the growth of harmful fungi that cause illnesses such as ringworm.

Drug Name	Company Name	MOA	ROA
DBI-001	DermBiont	Undefined mechanism	Topical

Detailed list of emerging therapies in Multiple Myeloma is provided in the final report.

Leading Companies in the Ringworm Market:

The market research report by IMARC encompasses a comprehensive analysis of the competitive landscape in the market. Across the global ringworm market, several leading companies are at the forefront of developing integrated platforms to enhance the management of ringworm. Some of the major players include Sebela Pharmaceuticals, Novartis, and Kaken Pharmaceutical. These companies are driving innovation in the ringworm market through continuous research, diagnostic tools, and expanding their product offerings to meet the growing demand for the illness.

Key Players in Ringworm Market:

The key players in the Ringworm market who are in different phases of developing different therapies are Sebela Pharmaceuticals, Novartis, Kaken Pharmaceutical, DermBiont, and Others.

Key Players

Regional Analysis:

The major markets for ringworms include the United States, Germany, France, the United Kingdom, Italy, Spain, and Japan. According to projections by IMARC, the United States has the largest patient pool for ringworm while also representing the biggest market for its treatment. This can be attributed to the rising popularity of telemedicine and point-of-care diagnostic tools in the U.S. that ensure wider accessibility to healthcare services.

Moreover, one significant driver is the development of advanced diagnostic tools, such as PCR assays and dermoscopy, which enable rapid and accurate identification of dermatophyte infections. These technologies improve early diagnosis and timely intervention, reducing complications and driving demand for antifungal therapies.

Besides this, the market also benefits from the growing range of innovative treatment options. Novel antifungal agents with enhanced efficacy and safety profiles, including topical and oral formulations, address the limitations of traditional therapies. Long-acting topical treatments and combination therapies are gaining traction for their ability to improve adherence and outcomes.

Key information covered in the report.

Base Year: 2023
Historical Period: 2018-2023
Market Forecast: 2024-2034

Countries Covered

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the ringworm market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the ringworm market
Reimbursement scenario in the market
In-market and pipeline drugs

Competitive Landscape:

This report offers a comprehensive analysis of current ringworm marketed drugs and late-stage pipeline drugs.

In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. Across the six major continents and 100+ countries, we work alongside our business partners as one team with a common ambition to achieve unparallelled results, gain a competitive edge, and transform industries. IMARC Group excels in understanding its clients’ business priorities and delivering tailored solutions that drive meaningful outcomes. Our client base spans over 3,000 organizations in the private, public, and social sectors, ranging from high-growth startups to Fortune 500 companies.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Phone Number: - +1 631 791 1145, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Ringworm Market Size to Grow at a CAGR of 3.49% during 2024-2034, Impelled by Advancements in Early Detection

Purchase Options New Year Sale

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.